Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266886 · ClinicalTrials.gov registry record · NA
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
A NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT04266886: Active NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
NCT04266886 is a NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 152 participants, below the 396-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04266886, a NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.
Primary Outcome
Will assess proportion of participants who listen to the complete audio file in the preoperative holding area.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- PROCEDURE Hypnotherapy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-09-11 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT04266886 still lists
NCT04266886 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 396-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04266886 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04266886 about?
NCT04266886 is a clinical study titled "Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer". This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.
What is the current status of trial NCT04266886?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2018-09-11. Estimated completion is 2027-12-31.
What conditions does trial NCT04266886 study?
This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm, Metastatic Cervical Cancer, Recurrent Malignant Female Reproductive System Neoplasm.
What interventions are being tested in trial NCT04266886?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Hypnotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT04266886?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04266886 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Female Reproductive System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04266886's enrollment target sits among peer trials
152 9th of 18 higher than 10 of 18 other Malignant Female Reproductive System Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Female Reproductive System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
ACTIVE NOT RECRUITING · NA
-
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
ACTIVE NOT RECRUITING · NA
-
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer
COMPLETED · NA
-
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI